Analysis of Benefit Cost Ratio (BCR) of synthetic fungicides and bioagent (Pseudomonas fluorescens) against brown spot disease of rice caused by Helminthosporium oryzae
KVK, ICAR, Senapati District, Manipur and Division of Nematology, ICAR-IARI, New Delhi, India.
Research Article
World Journal of Advanced Research and Reviews, 2021, 12(01), 481–486
Publication history:
Received on 19 September 2021; revised on 25 October 2021; accepted on 27 October 2021
Abstract:
BCR analysis for five selected fungicides and bioagent (Pseudomonas fluorescens) recorded highest in Propiconazole (1.72:1) followed by Propineb (1.47:1), bioagent (P. fluorescens) (1.46:1), Myclobutanil (1.45:1), Carbendazim (1.34:1), Thiopanate (1.33:1) and in Control (1.13:1). This inferred that in treatment Propiconazole investment of Re.1.00 will generate gross income of Rs.1.72 or net return (Re.0.72) and net return following other treatments i.e, Propineb (Re. 0.47), P. fluorescens (Re.0.46), Myclobutanil (Re.0.45), Carbendazim (Re.0.34), Thiophanate (Re.0.33) and in case of control (Re.0.13).
Keywords:
Helminthosporium oryzae; Synthetic fungicides; Bioagent; Pseudomonas fluorescens; Benefit cost ratio; Gross return; Net profit
Full text article in PDF:
Copyright information:
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0